The U.S. government is in negotiations with Moderna to potentially secure additional Covid-19 vaccine doses to supply to the world, according to a person familiar.
The discussions may lead to a similar number of doses purchased as a deal revealed Wednesday with Pfizer, said the person, who declined to be named because the negotiations aren't public.
CNBC Health & Science
Read CNBC's latest global coverage of the Covid pandemic:
J&J CEO says people will need Covid vaccine with annual flu shot for next several years as variants spread
Half of Americans 12 and older are fully vaccinated as daily Covid case counts remain low
U.S. CDC eases travel recommendations on 61 countries, including Japan
Fauci says U.S. must vaccinate more people before Delta becomes dominant Covid variant
Florida, Alabama discontinue daily Covid data reporting in shift to 'next phase' of pandemic
President Joe Biden is expected to announce at the G7 summit that the U.S. has bought 500 million doses of the Pfizer/BioNTech vaccine to share to share through the global Covax alliance for donation to 92 lower-income countries and the African Union over the next year, according to another person familiar. The news was first reported by the Washington Post and New York Times.
The Pfizer doses will be purchased at a not-for-profit price, the person said. The terms of a potential Moderna deal weren't immediately clear.
Source: Read Full Article